New export license required for synthetic DNA sent abroad
H.R. 6624 — Biological Intellectual Property Protection Act of 2025 · Filed by Warren Davidson (R-OH) · 11 cosponsors · Introduced Dec 11, 2025 · Reported out
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the U.S. government to issue export licenses for synthetic DNA and RNA sequences being sent to foreign entities tied to countries of concern (primarily China). It establishes that such genetic material—whether designed by humans or AI—cannot be exported without government approval, citing national security risks that China may use the information to advance its military and intelligence capabilities.
Why we flagged it
The bill's core mechanism is a licensing requirement for exports of synthetic DNA/RNA sequences to foreign entities of concern, framed as a national security measure to prevent intellectual property theft and military modernization by adversaries.
What the text implies
- The definition of 'foreign entity of concern' is broad and includes any foreign person 'owned, directed, or controlled by' a government entity or foreign person of a country of concern—potentially capturing U.S. subsidiaries of foreign companies or joint ventures with opaque ownership structures.
- The licensing requirement applies to 'digital sequences'—binary files representing DNA/RNA—which may capture not just physical exports but also digital transmission of genetic designs, potentially affecting academic collaboration and open-source biotech research.
The full analysis lists 4 implications of this text.
Who stands to gain
U.S. biotechnology and synthetic biology companies (protected from IP theft); U.S. defense and intelligence contractors (reduced foreign access to dual-use biotech)